Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;48:724-729
Published online before print September 11, 2006, doi: 10.1161/01.HYP.0000238159.19614.ce
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/4/724    most recent
01.HYP.0000238159.19614.cev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fang, Y.
Right arrow Articles by Liu, Z.-Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fang, Y.
Right arrow Articles by Liu, Z.-Q.
Related Collections
Right arrow Hypertrophy
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2006;48:724.)
© 2006 American Heart Association, Inc.


Original Articles

Salt Loading on Plasma Asymmetrical Dimethylarginine and the Protective Role of Potassium Supplement in Normotensive Salt-Sensitive Asians

Yuan Fang; Jian-Jun Mu; Lang-Chong He; Si-Cen Wang; Zhi-Quan Liu

From the Cardiovascular Research Institute of No 1 Hospital (Y.F., J.-J.M., Z.-Q.L.) and the Department of Pharmacology (L.-C.H., S.-C.W.), Xi’an Jiaotong University Medical School, Shaanxi, China.

Correspondence to Zhi-Quan Liu, Cardiovascular Research Institute, No 1 Hospital of Xi’an Jiaotong University Medical School, 74 Xiaozhai West Rd, Xi’an, Shaanxi, China. E-mail liuziqan{at}public.xa.sn.cn

Asymmetrical dimethylarginine (ADMA) is an endogenous inhibitor of NO synthase. Because endothelial NO pathway is compromised in patients with salt-sensitive hypertension, we investigated whether the plasma ADMA can be modulated by chronic salt loading in normotensive salt-sensitive persons and its relationship with NO, and we further determined whether or not dietary potassium supplementation can reverse them. Sixty normotensive subjects (aged 20 to 60 years) were selected from a rural community of Northern China. All of the people were sequentially maintained on a low-salt diet for 7 days (3 g/day, NaCl), then a high-salt diet for 7 days (18 g/day), and high-salt diet with potassium supplementation for another 7 days (4.5 g/day, KCl). After salt loading, the plasma ADMA concentrations increased significantly in salt-sensitive subjects (0.89±0.02 µmol/L versus 0.51±0.02 µmol/L; P<0.05), whereas the plasma NOx levels reduced considerably (41.8±2.1 µmol/L versus 63.5±2.1 µmol/L; P<0.01). All of the abnormalities normalized when dietary potassium were supplemented (0.52±0.03 µmol/L versus 0.89±0.02 µmol/L for ADMA and 58.1±0.9 µmol/L versus 41.8±2.1 µmol/L for NOx). Statistically significant correlations were found among plasma ADMA level, the mean blood pressure, and the level of NO after salt loading in normotensive salt sensitive individuals. Our study indicates that high dietary potassium intake reduces blood pressure and ADMA levels while increasing NO bioactivity in normotensive salt-sensitive but not salt-resistant Asian subjects after salt loading.


Key Words: sodium • potassium • nitric oxide • hypertension, sodium-dependent




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Oberleithner, C. Callies, K. Kusche-Vihrog, H. Schillers, V. Shahin, C. Riethmuller, G. A. MacGregor, and H. E. de Wardener
Potassium softens vascular endothelium and increases nitric oxide release
PNAS, February 24, 2009; 106(8): 2829 - 2834.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. M Dickinson, J. B Keogh, and P. M Clifton
Effects of a low-salt diet on flow-mediated dilatation in humans
Am. J. Clinical Nutrition, February 1, 2009; 89(2): 485 - 490.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Mimran and G. du Cailar
Dietary sodium: the dark horse amongst cardiovascular and renal risk factors
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2138 - 2141.
[Full Text] [PDF]